Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms

Hematological Oncology, EarlyView.

Source: Hematological Oncology - August 3, 2018 Category: Hematology Authors: Tariq I.Mughal , ThomasLion , OmarAbdel ‐Wahab , RubenMesa , Robyn M.Scherber , DaniloPerrotti , MichaelMauro , SrdanVerstovsek , GiuseppeSaglio , Richard A.Van Etten , RobertKralovics Source Type: research